RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference
GLEN ROCK, NJ--(Marketwired - Sep 8, 2017) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of respiratory disorders, including sleep apnea, opioid …